Early aspirin after mitral valve repair: safety and effectiveness
Part of Heart & circulation clinical trials.
This study tests whether starting aspirin early after mitral valve repair is safe and effective compared to standard care. It's for adults who have had this heart surgery and have a low risk of bleeding or stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have had a mitral valve repair with a ring (and possibly other minor heart repairs at the same time).
- Your heart had a normal rhythm before surgery, or if you had atrial fibrillation, your stroke risk score is very low or your rhythm was corrected during surgery.
- You are not at high risk for bleeding (no recent bleeding, low blood counts, or ulcers).
- You have not had a heart attack in the last month or a stroke in the last 3 months, and you do not have severe kidney or liver disease, or active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special protection device used during a heart procedure (called M-TEER) that repairs a leaky mitral valve. The device is designed to catch any small debris or blood clots that might break loose during the procedure, reducing the risk of a stroke or brain injury.
This trial compares doing mitral valve repair early versus closely monitoring without surgery in people who have severe leakage but no symptoms. It aims to see whether early repair helps prevent future heart problems.
This trial compares aspirin to warfarin in the first six months after receiving a bioprosthetic (tissue) heart valve. It aims to find which treatment better prevents blood clots without causing excessive bleeding.
This trial compares doing mitral valve repair early with closely monitoring symptoms instead, for people who have severe leakage but feel well. It may help determine whether early surgery prevents future heart problems without causing unnecessary risk.
This trial tests different blood-thinning medicines after a mitral valve repair procedure (TEER) in people who do not need long-term blood thinners. It aims to find the safest and most effective strategy to prevent blood clots.
This study tests whether a procedure called catheter ablation, which uses heat or cold to fix irregular heartbeats, is safe and effective for people who have atrial fibrillation and have recently had a mitral valve repair. If you qualify, it might help restore a normal heart rhythm and improve your symptoms.
Hear when a new Mitral Valve Repair Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.